感染症におけるサイトカイン・ケモカイン・ハンドブック<br>Cytokines and Chemokines in Infectious Diseases Handbook (Infectious Disease (Totowa, N.J.).)

個数:
  • ポイントキャンペーン

感染症におけるサイトカイン・ケモカイン・ハンドブック
Cytokines and Chemokines in Infectious Diseases Handbook (Infectious Disease (Totowa, N.J.).)

  • ウェブストア価格 ¥32,750(本体¥29,773)
  • Humana Pr Inc(2003/03発売)
  • 外貨定価 US$ 169.99
  • ゴールデンウィーク ポイント2倍キャンペーン対象商品(5/6まで)
  • ポイント 594pt
  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 436 p.
  • 言語 ENG
  • 商品コード 9780896039087
  • DDC分類 616.90479

基本説明

International leaders in the field discuss the role of cytokines and chemokines in bacterial, viral, fungal, and parasitic infections.

Full Description

A comprehensive review of what is known about the role of cytokines and chemokines in a variety of human infectious diseases, including gram-negative and -positive infections, listeriosis, mycobacterial infections, lyme arthritis, pneumonia, fungal infections, HIV, leishmaniasis, and sepsis. The authors demonstrate the different cytokine and chemokine production profiles in response to a wide variety of pathogens and the importance of host genetic factors in determining the type and magnitude of responses to a given microorganism. They also critically evaluate the use of cytokines and anticytokines in the treatment of infectious diseases and show how knowledge of cytokine pleiotropic effects, redundancy, and the complexity of the cytokine network has led to better design and better outcomes in cytokine-based therapies for specific infections.

Contents

Introduction: Cytokine Biology Relevant to Infectious Diseases.- I Cytokines in Infectious Diseases.- 1 Leptin: Its Role in Immunomodulation and Susceptibility to Infection.- 2 Cytokine Gene Polymorphism and Host Susceptibility to Infection.- II Cytokines in Gram-Negative Infections.- 3 Proinflammatory and Anti-Inflammatory Cytokines as Mediators of Gram-Negative Sepsis.- 4 Host Response to Pathogenic Bacteria at Mucosal Sites.- 5 Macrophage Migration Inhibitory Factor as a Cytokine of Innate Immunity.- III Cytokines in Gram-Positive Infections.- 6 Cytokine Patterns in Severe Invasive Group A Streptococcal Infections.- 7 Superantigens and Bacterial DNA as Cytokine Inducers in Gram-Positive Sepsis.- 8 Cytokines and Chemokines in Listeriosis.- IV Cytokines in Mycobacterial Infections.- 9 Regulation of Cytokines and Chemokines in Human Mycobacterium tuberculosis Infection.- 10 Cytokines and Chemokines in Protective and Inflammatory Responses to Infection with Nontuberculous Mycobacteria.- 11 Human Interleukin-12—Interferon-? Axis in Protective Immunity to Mycobacteria.- 12 Role of Th1 Cytokines in Host Defenses Against Mycobacterium leprae.- V Cytokines in Other Bacterial Infections.- 13 Possible Role of Molecular Mimicry in Lyme Arthritis.- 14 Cytokine Responses in Patients with Pneumonia.- VI Cytokines in Fungal Infections.- 15 Cytokines and the Host Defense Against Aspergillus fumigatus.- 16 Cytokines of Innate and Adaptive Immunity to Candida albicans.- VII Cytokines in Parasitic Infections.- 17 Th1 and Th2 Cytokines in Leishmaniasis.- 18 Cytokines in the Regulation of Innate and Adaptive Immunity to Toxoplasma gondii.- VIII Cytokines in Viral Infections.- 19 Viroceptors: Virus-Encoded Receptors for Cytokines and Chemokines.- 20 Chemokines and Chemokine Receptors inHIV Infection.- 21 Cytokines in Viral Hepatitis.- IX Cytokines as Therapeutic Agents in Infectious Diseases.- 22 Interferon-? in the Treatment of Infectious Diseases.- 23 Interleukin-2 for the Treatment of HIV Infection.- 24 Clinical Applications of G-CSF and GM-CSF in the Treatment of Infectious Diseases.- X Anticytokine-Based Therapy in Treatment of Infectious Diseases.- 25 Anticytokine Therapies in Patients with Severe Sepsis and Septic Shock.- 26 Intravenous Immunoglobulin Adjunctive Therapy in Patients with Streptococcal Toxic Shock Syndrome and Necrotizing Fasciitis.